CD274 and neoplasm: Positive PD-L1 expression in NSCLC patients is observed in 50% to 70% of cases, and high expression in ≥50% of tumor cells in 7.4%–10.6% of NSCLCs patients [6,7,8,9,10,11,12,13,14].